Navigation Links
Cumberland Pharmaceuticals Reports Second Quarter 2010 Financial Results
Date:8/16/2010

nt, providing more time for a donor organ to become available. In May 2010, the FDA accepted the sNDA and granted a priority review. In addition to expanded labeling, the Company has requested additional exclusivity for the product and, if approved, expects to begin marketing it with the new indication in 2011.

International MarketsAcetadote Approved for Marketing in Australia

Cumberland has granted an exclusive license to Phebra Pty Ltd., an Australian-based specialty pharmaceutical company, to commercialize Acetadote in Australia. In April 2010, the Therapeutics Goods Administration (TGA), which regulates drugs and medical devices in Australia, approved Acetadote for marketing. Phebra is preparing for the Australian launch of the product, which it expects to commence this year. Under the agreement, Phebra is responsible for ongoing regulatory requirements, marketing, distribution and sales of Acetadote in Australia, New Zealand and the Asia Pacific while Cumberland maintains responsibility for product formulation, development and manufacturing. Cumberland receives milestone payments and royalties on future sales in exchange for the product license.

Caldolor Launched for Compassionate Use in Australia

In 2009, Cumberland entered into an exclusive agreement with Phebra Pty Ltd. for distribution of Caldolor in Australia and New Zealand. The Therapeutics Goods Administration operates compassionate use programs allowing patients with critical clinical needs to access products not yet approved. In April 2010, Phebra made Caldolor available in Australia for compassionate use.

Submission of New Drug Application for Caldolor in South Korea

In December 2009, Cumberland entered into an exclusive agreement with DB Pharm Korea Co. Ltd., a Korean-based pharmaceutical company, for the commercialization of Caldolor in South Korea. Under the terms of the agreement DB Pharm Korea is responsible for seeking regu
'/>"/>

SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Cumberland Pharmaceuticals to Present at the Wells Fargo Healthcare Conference in Boston on June 23, 2010
2. Cumberland Pharmaceuticals to Present at Jefferies Global Life Sciences Conference in New York on June 8, 2010
3. Cumberland Pharmaceuticals To Announce First Quarter 2010 Financial Results on May 13, 2010
4. Cumberland Pharmaceuticals Partners in Canada With Alveda Pharmaceuticals to Commercialize Caldolor(R)
5. Cumberland Pharmaceuticals Reports 24% Increase in Net Revenue With Full Year 2009 Financial Results
6. Cumberland Pharmaceuticals Donates Caldolor(R) to Haitian Relief Effort
7. Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
8. Cumberland Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 10, 2009
9. Ferring Pharmaceuticals FIRMAGON® Joins Race to End Prostate Cancer as Official Sponsor of the Great Prostate Cancer Challenge / Dash for Dad
10. Jiangbo Pharmaceuticals Announces the Commercial Launch of Felodipine Sustained Release Tablets
11. Lotus Pharmaceuticals Reports Strong Second Quarter 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... WEST JORDAN, Utah , Aug. 29, 2014 /PRNewswire/ ... Imaging Solutions, has acquired Polaris Medical Imaging, a leader ... CT scanners. This strategic acquisition allows BC Technical to ... their capabilities, specifically within MR and CT modalities. ... lower cost service," said Mark Alvarez , president ...
(Date:8/29/2014)... Research and Markets has announced the addition ... Pipeline Insight 2014" report to their offering. ... eradicate the prevalence of cancer have achieved limited success ... specificity, safety and large number of side effects, which ... It has been discovered that peptides can be used ...
(Date:8/29/2014)... According to a new ... type (SFE, Cold Pressed, Organic Solvent, & Others), and ... Fragrance, & Others) - Global Trends & Forecast ... the Amaranth Seed Oil Market with an analysis ... of value. The Amaranth Seed Oil Market size ...
Breaking Medicine Technology:BC Technical Acquires Polaris Medical Imaging 2Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4
... SAN DIEGO, May 26, 2011 Volcano Corporation ... following statement: Earlier this year, the ... a wholly-owned subsidiary of St. Jude Medical, that ... misappropriated LightLab,s confidential information in connection for use ...
... YORK, May 26, 2011 A new prostate cancer ... Medicine comparing surgical treatment to "watchful waiting" ... cancer and currently debating their treatment options. ... the most commonly offered clinical options for early prostate ...
Cached Medicine Technology:Statement From Volcano Corporation on Latest St. Jude Lawsuit 2Robotic Prostatectomy Expert Dr. David Samadi on a High Impact Study Advocating Aggressive Early-Stage Prostate Cancer Treatment 2Robotic Prostatectomy Expert Dr. David Samadi on a High Impact Study Advocating Aggressive Early-Stage Prostate Cancer Treatment 3
(Date:9/1/2014)... Building on the success of the 2014 ... Breathing Academy (ASBA) has officially announced its 2015 ... The event will be taking place at the DoubleTree ... This years’ event promises to be yet another educational ... In recent years, Pro Player Health Alliance ...
(Date:9/1/2014)... health and substance use problems in adolescents but ... consequences of cyberbullying and also be beneficial for ... Ph.D., of McGill University, Montreal, Canada, and colleagues. ... experienced recent online bullying and cyberbullying, like traditional ... problems in teens as well as the misuse ...
(Date:9/1/2014)... You may be able to convince your brain that healthy ... The study included eight overweight and obese people who were ... how people react to different foods. These participants were compared ... who weren,t in the program. Both groups had MRI ... six months later. The scans revealed that the people in ...
(Date:9/1/2014)... Currently, scientists continue to face ... Alzheimer's disease (AD), which reflects their poor understanding ... diagnosis of the disease, especially in its early ... tests. In 2014, after decades that have ... the medicine world, there are still no disease-modifying ...
(Date:9/1/2014)... 01, 2014 "Women struggle with weight ... daily changes begin as early as 15, if not ... negotiating the ups and downs of hormone related weight ... even healthy sizes seems to rage against the hidden ... woman in her 40's begin to face menopause and ...
Breaking Medicine News(10 mins):Health News:Pro Player Health Alliance Confirms Big Name Speakers at 2015 American Sleep and Breathing Academy Conference 2Health News:Pro Player Health Alliance Confirms Big Name Speakers at 2015 American Sleep and Breathing Academy Conference 3Health News:Pro Player Health Alliance Confirms Big Name Speakers at 2015 American Sleep and Breathing Academy Conference 4Health News:Family dinners good for teens' mental health, could protect from cyberbullying 2Health News:Family dinners good for teens' mental health, could protect from cyberbullying 3Health News:Train Your Brain to Choose Fruit Salad Over French Fries 2Health News:Early Stage Minimally Invasive Candidate AD Biomarkers Reviewed in New Study by Biopharm Reports Available at MarketPublishers.com 2Health News:Early Stage Minimally Invasive Candidate AD Biomarkers Reviewed in New Study by Biopharm Reports Available at MarketPublishers.com 3Health News:Female Hormonal Imbalances - Can’t Seem to Shed Those Extra Pounds? Discussion with Medical Expert Dr. Clairborne on Dr. Carol Francis Talk Radio Today 2Health News:Female Hormonal Imbalances - Can’t Seem to Shed Those Extra Pounds? Discussion with Medical Expert Dr. Clairborne on Dr. Carol Francis Talk Radio Today 3
... Pa., Nov. 21 Universal,Health Services, Inc. (NYSE: ... to pay a cash dividend of $0.08 per share ... December 3, 2007., Universal Health Services, Inc. is ... and behavioral health hospitals, and,ambulatory centers nationwide and in ...
... counters idea that seniors are by nature sedentary , WEDNESDAY, ... believe that becoming less active is just a normal part ... to dispel such notions. , The program led to a ... of walking participants did each week, according to the leaders ...
... egg follicles, mouse study shows , , WEDNESDAY, Nov. 21 ... by which a mother,s smoking before and after pregnancy ... two-thirds. , Cigarette smoking during pregnancy has been shown ... woman,s offspring, but this is the first study to ...
... at St. Jude Children,s Research Hospital have discovered a ... amok and damaging the body. The finding could lead ... vaccines; for autoimmune diseases, such as Type 1 diabetes; ... (IBD) and asthma. , The St. Jude team ...
... would you do if you,suddenly found yourself unable to ... a drinker, exercised and got an adequate amount of,sleep ... suffered a stroke. In his new,book, "My Glitch: Personal ... -- http://www.authorhouse.com ), Beel shares his,experiences of being ...
... 8 a.m. CT, MINNEAPOLIS, Nov. 21 Vital ... enterprise-wide advanced,visualization and analysis solutions, will Webcast its analyst ... of the Radiological,Society of North America (RSNA), on Monday, ... D. Miller, president and chief executive officer, and Michael ...
Cached Medicine News:Health News:Aging Isn't About Slowing Down, Experts Say 2Health News:Smoking Before, After Pregnancy Harms Daughters' Fertility 2Health News:Smoking Before, After Pregnancy Harms Daughters' Fertility 3Health News:Smoking Before, After Pregnancy Harms Daughters' Fertility 4Health News:St. Jude finds molecule that could improve cancer vaccines and therapy for other diseases 2Health News:St. Jude finds molecule that could improve cancer vaccines and therapy for other diseases 3Health News:The Blessing of a Brain Injury: Author Survives Injury to Brain Following Stroke, Uses Injury as Fuel to Overcome Odds 2Health News:Vital Images to Webcast Analyst and Investor Meeting at RSNA on Monday, November 26 2
... Autoref / Ker Accuref K ... inch LCD color monitor. 3 ... range. 2.3 mm Minimum pupil ... light adjuster. Auto start function. ...
... is the child-friendly, portable autorefractor that ... adults. It can perform objective refraction ... cm) away even through glasses and ... and sounds engage the patient throughout ...
Neomycin and Polymyxin B sulfates and Dexamethasone ophthalmic ointment is a multiple dose anti-infective steroid combination in sterile ointment form for topical applications....
Optoelectronic stimulator, "ganzfeld" stimulations for flash VEP, flash ERG and sensory EOG. Pattern stimulations for ERG and VEP, multifocal stimulations for ERG and VEP, complies with international...
Medicine Products: